Filtered By:
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 153 results found since Jan 2013.
HPV vaccine for teen boys: Dyadic analysis of parents’ and sons’ beliefs and willingness
Conclusion Parents and sons were more willing to have the son receive HPV vaccine if they had higher anticipated regret about potential HPV infection and lower concerns about side effects. Communication campaigns should target these beliefs to increase parents’ and sons’ willingness to seek HPV vaccination.
Source: Preventive Medicine - July 18, 2015 Category: Global & Universal Source Type: research
A Case Study of Oral Cancer Related to Human Papilloma Virus
ConclusionSymptoms of HPV‐related oropharyngeal cancer are elusive and make early diagnosis challenging. Although rare, the transmission and eventual development of HPV‐related oropharyngeal cancer is a valid concern for intimate partners. Providing education for nurses can increase awareness in women about the possibility of developing this disease and may lead to early detection and treatment. Increased awareness of the relationship between HPV and oropharyngeal cancer can also influence the choice for HPV vaccination.
Source: Journal of Obstetric, Gynecologic, and Neonatal Nursing - June 4, 2015 Category: Nursing Authors: Rose M. Scaffidi, Cheryle Eisele Tags: Women's Health Source Type: research
Hypothesis: Human papillomavirus vaccination syndrome—small fiber neuropathy and dysautonomia could be its underlying pathogenesis
This article forwards the hypothesis that small fiber neuropathy and dysautonomia could be the common underlying pathogenesis to the group of rare, but severe reactions that follow HPV vaccination. Clinicians should be aware of the possible association between HPV vaccination and the development of these difficult to diagnose painful dysautonomic syndromes.
Source: Clinical Rheumatology - May 20, 2015 Category: Rheumatology Source Type: research
Stopping Cancer Before It Starts
On May 20, 2015, New York State will host its Cancer Prevention Summit in Manhattan.
This bold initiative is the work of the New York State Commissioner of Health, Dr. Howard Zucker, and his colleagues at the New York State Department of Health. Many health related organizations in New York are participating in the Summit, and the audience will be challenged with action points. I am honored to participate in the Cancer Prevention Summit as a speaker, and will introduce the keynote speaker, Dr. Graham Colditz, an internationally recognized leader in the prevention of cancer and other diseases.
The Summit's focus is the p...
Source: Science - The Huffington Post - May 18, 2015 Category: Science Source Type: news
Relaxation and guided imagery do not reduce stress, pain and unpleasantness for 11‐ to 12‐year‐old girls during vaccinations
ConclusionRelaxation and guided imagery did not prove beneficial during the vaccination of 11‐ to 12‐year‐old girls and is not recommended as a regular nursing intervention. However, further research is needed into effective techniques to help children who experience pain unpleasantness in connection with needle procedures.
Source: Acta Paediatrica - April 22, 2015 Category: Pediatrics Authors: Stefan Nilsson, Maria Forsner, Berit Finnström, Evalotte Mörelius Tags: Regular Article Source Type: research
By 2020, The Most Common HPV-Related Cancer Will Affect Men
While currently recommended for both boys and girls, the HPV vaccine was initially marketed -- and is still thought of -- as a way to protect young women and girls from cervical, vaginal and vulvar cancer. Boys, it's been commonly thought, should be vaccinated primarily to benefit herd immunity and any future female partners.
But a new analysis from researchers at the Princess Margaret Cancer Center in Toronto, Canada, points out that boys who get the vaccine receive important protection as well, not only against genital warts, but against HPV strains that cause oropharyngeal (mouth and throat) cancer.
"We believe this s...
Source: Science - The Huffington Post - April 20, 2015 Category: Science Source Type: news
Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus.
CONCLUSIONS: In a population referred for symptoms of orthostatic intolerance and other symptoms consistent with autonomic dysfunction that began in close temporal association with a quadrivalent HPV vaccination, we identified a 60% prevalence of POTS. Further work is urgently needed to elucidate the potential for a causal link between the vaccine and circulatory abnormalities and to establish targeted treatment options for the affected patients.
PMID: 25882168 [PubMed - as supplied by publisher]
Source: Vaccine - April 13, 2015 Category: Allergy & Immunology Authors: Brinth LS, Pors K, Theibel AC, Mehlsen J Tags: Vaccine Source Type: research
Relaxation and guided imagery do not reduce stress, pain and unpleasantness for 11 to 12‐year‐old girls during vaccinations
ConclusionRelaxation and guided imagery did not prove beneficial during the vaccination of 11 to 12‐year‐old girls and is not recommended as a regular nursing intervention. However, further research is needed into effective techniques to help children who experience pain unpleasantness in connection with needle procedures.This article is protected by copyright. All rights reserved.
Source: Acta Paediatrica - March 12, 2015 Category: Pediatrics Authors: Stefan Nilsson, Maria Forsner, Berit Finnström, Evalotte Mörelius Tags: Regular Article Source Type: research
Awareness of human papillomavirus and factors associated with intention to obtain HPV vaccination among Korean youth: quasi experimental study
Conclusions:
Increased HPV knowledge could positively influence the intention to obtain the HPV vaccination among youth. Thus, HPV education at elementary school would be helpful to make students aware of HPV and the importance of HPV prevention.
Source: BMC International Health and Human Rights - February 21, 2015 Category: Global & Universal Authors: Hae Kim Source Type: research
New HPV vaccine may protect against 90% of cervical cancers
Conclusion
This double-blind randomised trial has shown that the new HPV vaccine provides increased protection from additional strains of HPV that cause cervical, vulval and vaginal cancers.
Strengths of the study include:
Blinding of the pathologists to the vaccine type, and blinding of the participants (they didn't know which vaccine they had been given), which reduces any bias – a double-blind randomised controlled trial is considered the gold standard of how best to assess a treatment or intervention.
The large number of women included in the study, with diverse ethnic backgrounds, makes it likely that the res...
Source: NHS News Feed - February 20, 2015 Category: Consumer Health News Tags: Cancer Medication Source Type: news
The FDA Approves a New HPV Vaccine Containing Over Twice as Much Aluminum As its Predecessor
According to recent reports, the FDA has approved yet another HPV vaccine, despite documented safety issues and the new vaccine containing an exceptionally high level of aluminum, a known neurotoxin.
Until now, only two vaccines have been manufactured to protect men and women against human papillomavirus (HPV), a virus believed to be the leading cause of cervical cancer: Cervarix, which is believed to protect against strains 16 and 18 of the virus, and Gardasil, which is believed to protect against strains 6, 11, 16 and 18.
//
A Third HPV Vaccine Hits the Market
In December 2014, Gardasil 9 vaccine, manu...
Source: vactruth.com - February 1, 2015 Category: Allergy & Immunology Authors: Christina England Tags: Christina England Physical Top Stories aluminum hydroxide Food and Drug Administration (FDA) Gardasil 9 HPV Vaccine Merck Sharp and Dohme Source Type: blogs
Pain in Adolescent Girls Receiving Human Papillomavirus Vaccine With Concomitantly Administered Vaccines
Using the Faces Pain Scale - Revised, we assessed injection site pain 10 minutes after vaccination in young females randomized to receive either quadrivalent human papillomavirus vaccine (HPV4) before or after concomitantly administered vaccines. Although pain was modestly more after HPV4 injection than after other vaccines, the pain intensity after HPV4 injection was significantly less in those who received HPV4 before receiving other concomitant vaccines.
Source: The Pediatric Infectious Disease Journal - January 17, 2015 Category: Infectious Diseases Tags: Vaccine Reports Source Type: research
January Cervical Cancer Month: Progress Is Promising
January is Cervical Cancer Month. So it is time to look at what has been accomplished recently in control of this disease.
Getting treatment for advanced cervical cancer is challenging. Patients often have pelvic pain, sometimes with blockage of intestines and the urinary tract. Regrettably many patients have fistulas (holes) develop where they leak urine or stool through the skin, vagina or bladder. These are cruel consequences of failed cancer control. About 13,000 women will develop cervical cancer every year, and tragically 4,000 will die of the illness.
In 2014, the FDA approved a new treatment for advanced cervical...
Source: Healthy Living - The Huffington Post - January 9, 2015 Category: Consumer Health News Source Type: news
New HPV Vaccine Is Even More Effective Against Cancer
WASHINGTON (AP) — The drugmaker Merck & Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer.
The Food and Drug Administration approved the company's Gardasil 9, which protects against nine strains of the virus called HPV, or human papillomavirus. That's up from four strains covered by the original Gardasil vaccine approved in 2006. The FDA said Wednesday the updated Gardasil has the potential to prevent roughly 90 percent of cervical, vulvar, vaginal and anal cancers. Original Gardasil protec...
Source: Science - The Huffington Post - December 11, 2014 Category: Science Source Type: news
Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review
Publication date: November–December 2014 Source:The Brazilian Journal of Infectious Diseases, Volume 18, Issue 6 Author(s): Ana Katherine Gonçalves , Ricardo Ney Cobucci , Hugo Marcus Rodrigues , Amanda Gosson de Melo , Paulo César Giraldo Recently, many studies have evaluated HPV vaccine safety and adverse effects. Two vaccines have been recently evaluated in randomized controlled trials: the bivalent vaccine for HPV 16 and 18 (Cervarix, GlaxoSmithKline Biologicals, Rixensart, Belgium) and the quadrivalent vaccine for HPV 6, 11, 16, and 18 (Gardasil, Merck and Co., Inc., Whitehouse Station, NJ). We have performed a ...
Source: The Brazilian Journal of Infectious Diseases - November 22, 2014 Category: Infectious Diseases Source Type: research
